miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5

A new study in Spandidos Publications shows micro RNA-34a, a tumor suppressor in various types of cancer, enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F transcription factor 5 (E2F5), a key oncogenic protein.